Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Doliprane Suppositories 150mg²


Generally acceptable

May be acceptable
Risk of skin rash in breastfed infant
Doliprane Suppositories 150mg² :
Type Medicine Non Marketed
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Opella Healthcare
Responsible Party Opella Healthcare France SAS
Origin France
Manufacturer Opella Healthcare International
Origin France
ATC N02BE01

Your comment will appear shortly after approval

Doliprane Suppositories 150mg² :

Revision Date : 24/02/2017


Effect Frequency
Agranulocytosis Not known
Anal irritation Not known
Anaphylactic shock Rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Bronchospasm Not known
Cytolytic hepatitis Not known
Erythema Rare
Fixed pigmented erythema Not known
Haemolytic anemia Not known
Hepatitis acute Not known
Hypersensitivity reactions Rare
Kounis syndrome Not known
Leucopenia (Leukopenia) Very rare
Neutropenia Very rare
Serum transaminase increased Not known
Skin rash Rare
Thrombocytopenia (Thrombopenia) Very rare
Urticaria Rare

Different Units By MoH Code

Revision Date : 01/08/2008

Revision Date : 01/03/2012

Doliprane Suppositories 150mg² Doliprane Suppositories 150mg² Doliprane Suppositories 150mg² Doliprane Suppositories 150mg² Doliprane Suppositories 150mg² Doliprane Suppositories 150mg² Doliprane Suppositories 150mg²

Doliprane Suppositories 150mg²  MoH 11231 :
Form Suppository
Packaging Blisters (PVC/PE)
Package Size Box of 10
Strength 150mg
NSSF ✔
Quarantine ✘
Reg. Number 145721/1
Submission date 2021
Registration Year 01/08/2023
Archived Date 12/12/2024


NB : Double Registration in 2023 with different manufacturer

Price Comparison

● Country: France
● Package Size: 10
● Public Price: 2.35 EUR ( 227,658.60 LBP )
● Pack size unit used: 10
● Cost/Unit: 0,235 EUR ( 0.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info